Cellular heterogeneity of human fallopian tubes in normal and hydrosalpinx disease states identified using scRNA-seq.
Ulrich ND, Shen YC, Ma Q, Yang K, Hannum DF, Jones A, Machlin J, Randolph JF Jr, Smith YR, Schon SB, Shikanov A, Marsh EE, Lieberman R, Gurczynski SJ, Moore BB, Li JZ, Hammoud S.
Dev Cell. 2022 Apr 11;57(7):914-929.e7. doi: 10.1016/j.devcel.2022.02.017. Epub 2022 Mar 22.
PMID:35320732
Hydrosalpinx Sclerotherapy Before In Vitro Fertilization: Systematic Review and Meta-analysis.
Proc R Soc Med. 1955 Dec;48(12):1091. doi: 10.1177/003591575504801228.
PMID:19993864
Hydrosalpinx treatment before in-vitro fertilization: systematic review and network meta-analysis.
Pérez-Milán F, Caballero-Campo M, Carrera-Roig M, Moratalla-Bartolomé E, Domínguez-Arroyo JA, Alcázar-Zambrano JL, Alonso-Pacheco L, Carugno JA; Spanish Fertility Society Special Interest Group on Organic Reproductive Disorders.
Which patients with hydrosalpinx will benefit more from reproductive surgery to improve natural pregnancy outcomes?: A systematic review and meta-analysis.
Hao HJ, Wang ZH, Feng L, Zhao XL, Chen X.
Medicine (Baltimore). 2023 Feb 22;102(8):e32806. doi: 10.1097/MD.0000000000032806.
PMID:36827021
Effects of Hydrosalpinx on Endometrial Implantation Failures: Evaluating Salpingectomy in Women Undergoing in vitro fertilization.
Palagiano A, Cozzolino M, Ubaldi FM, Palagiano C, Coccia ME.
Rev Bras Ginecol Obstet. 2021 Apr;43(4):304-310. doi: 10.1055/s-0040-1722155. Epub 2021 Feb 18.